We wish you a merry Christmas and all the best for 2019!
PELyon has been awarded by the The Respiratory Effectiveness Group for the best oral abstract on “Therapeutic ratios predict asthma control in the Astrolab cohort” that was presented at the REG Summit 2018 on 22nd – 24th March 2018.
Presentation of PELyonPELyon conducts a broad range of research projects, with emphasis on pharmacoepidemiological studies, burden/cost of illness, adherence and Comparative Effectiveness Research.
PELyon consists of Medical Doctors, Epidemiologists, Project Managers, Data Managers and Statisticians, who combine their skills and experience to address current health-related issues.
PELyon aims at helping decision-makers (health authorities, biomedical industries, and healthcare settings) by offering tools that will enable them to choose between different therapeutic strategies or public health programmes.